For the Inventor, By the Inventor

Enter assignee name

St. Louis, MO, United States of America

Sequoia Sciences, Inc.

USPTO Granted Patents = 15

% Expired Patents = 20.0

EPO Patents = 3

Trademarks = 3

Forward Citations = 106

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Gary R Eldridge (15 out of 17 patents)

Steven M Martin (10 out of 12 patents)

Zhongping Huang (2 out of 2 patents)

4. Michael A Ellis (1 out of 19 patents)

5. Ronald Buckle (1 out of 3 patents)

6. Peter Guzzo (1 out of 43 patents)

7. Russell B Williams (1 out of 1 patent)

8. Courtney M Starks (1 out of 1 patent)

9. John Edward Reilly (1 out of 1 patent)

10. Lu Zeng (1 out of 3 patents)

11. Peader Cremin (1 out of 1 patent)

12. Chris Lee (1 out of 1 patent)

13. Helene C Vervoort (1 out of 1 patent)

14. Marilyn Ghanem (1 out of 1 patent)

15. Ronald Neil Buckle (0 patent)

15 patents: Sort by Forward Citations

1. 10137192 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2018-11-27),

2. 10058608 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2018-08-28),

3. 9878037 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2018-01-30),

4. 9562031 - Phenethyldihydrobenzodioxolones and methods of use (2017-02-07),

5. 9504743 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2016-11-29),

6. 9492522 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2016-11-15),

7. 9415101 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2016-08-16),

8. 9415097 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2016-08-16),

9. 9149522 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2015-10-06),

10. 9149521 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2015-10-06),

11. 9017698 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2015-04-28),

12. 8324264 - Inhibitors of bacterial biofilms and related methods (2012-12-04),

13. 7612045 - Compounds, compositions and methods for controlling biofilms and bacterial infections (2009-11-03),

14. 7604978 - Inhibition of biofilm formation (2009-10-20),

15. 7367933 - Screening of chemical compounds purified from biological sources (2008-05-06),

Sequoia Sciences, Inc. is a leading biotechnology company specializing in innovative research and development of pharmaceutical products. With a focus on improving human health and well-being, Sequoia Sciences is committed to discovering groundbreaking solutions through cutting-edge scientific technology. Our dedicated team of scientists and researchers continually strive for excellence in drug discovery and development, aiming to transform the landscape of healthcare with our advanced pharmaceutical interventions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

15 Patents

#136 in St. Louis, MO

#301 in Missouri

#21,026 in US

#39,846 in the World

St. Louis, MO, United States of America

Sequoia Sciences, Inc.

Forward Citations = 106

14 inventors:

Gary R Eldridge (15 out of 17 patents)

Steven M Martin (10 out of 12 patents)

Zhongping Huang (2 out of 2 patents)

4. Michael A Ellis (1 out of 19 patents)

5. Ronald Buckle (1 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…